Category:

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

California Governor Gavin Newsom signed into law last month new legislation that allows pharmacists in the state to initiate and dispense HIV medication without a prescription. The law, SB159, was amended to say that “a pharmacist may initiate and furnish HIV preexposure prophylaxis” and “a pharmacist may initiate and furnish HIV postexposure prophylaxis.” Previously, only pharmacists in specific collaborative practice agreements were able to dispense the drugs independently.In order to dispense either preexposure prophylaxis (PrEP) or postexposure prophylaxis (PEP), pharmacists will need to complete a boardapproved training program, according to the law...READ MORE

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

CVS Health Corp and its Omnicare unit were sued...by the U.S. government, which accused them of fraudulently billing Medicare and other programs for drugs for older and disabled people without valid prescriptions...The Department of Justice joined whistleblower litigation accusing Omnicare of violating the federal False Claims Act for illegally dispensing drugs to tens of thousands of patients in assisted living facilities, group homes for people with special needs, and other long-term care facilities...According to a civil complaint filed in Manhattan federal court, Omnicare would often assign new numbers to prescriptions after the original prescriptions expired or ran out of refills...The government said this enabled Omnicare to bill Medicare Medicaid, and Tricare...for hundreds of thousands of drugs, under what the company internally called “rollover” prescriptions, from 2010 to 2018...READ MORE

...I update our estimates of pharmacy economics and margins. Our analysis reveals that profits per prescription in 2018 were unchanged from the 2017 figures. However, the average pharmacy in the NCPA sample filled fewer prescriptions, causing the average pharmacy owner’s salary to decline for the fifth consecutive year...

1. Overall independent pharmacy profit margins have stabilized.
2. Independent pharmacies’ prescription profit margins also were stable.
3. Independent pharmacies’ generic dispensing rates matched those of the overall market.
4. The average pharmacist who owned a single pharmacy earned about $129,000 in 2018—down for the fifth consecutive year.
5. By the NCPA's count, the total number of independent pharmacies continues to drop.

Retail pharmacies account for a majority of the pharmacy industry’s dispensed prescriptions but a decreasing share of the industry’s revenues...This means that most of them lack access to the specialty drugs that now make up one-third of the pharmacy industry’s revenues...READ MORE

Pharmacists have taken their rightful place in the delivery of health care, engaging with patients and making a noticeable improvement in their patients’ health outcomes. As the clinical role of pharmacists has grown, so too has the imperative to fill an ever-increasing number of prescriptions in a day. As a result, pharmacy technology and automation companies are stepping up to the plate to ensure that pharmacists can juggle their role successfully...READ MORE

• Speeding up Dispensing
• Rethinking Processes
• Software and Workflow

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Consider the boom in pharmacies operated by physician practices. The growth in oral and patient self-injectable specialty drugs has encouraged physicians to dispense these products from their offices and clinics. For example, almost half of all oncology practices now dispense specialty drugs to their patients...the share of oncology practices dispensing prescriptions has declined for the first time in at least six years. I suspect that we are at a turning point in the growth of physician practice dispensing...this development reflects how PBMs and their plan sponsor clients are managing specialty channels...PBMs offer financial carrots that entice plan sponsor to shift prescriptions into PBM-owned specialty pharmacies. This dynamic creates novel competitive conflicts between historically separate drug channel participants. Meanwhile, physicians are learning the perils of competing with vertically-integrated channel organizations...READ MORE

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network